Martin S - Search Results

1

Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.

Psaltis PJ, Paton S, See F, Arthur A, Martin S, Itescu S, Worthley SG, Gronthos S, Zannettino AC. Psaltis PJ, et al. Among authors: martin s. J Cell Physiol. 2010 May;223(2):530-40. doi: 10.1002/jcp.22081. J Cell Physiol. 2010. PMID: 20162565

2

Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients.

Zannettino AC, Farrugia AN, Kortesidis A, Manavis J, To LB, Martin SK, Diamond P, Tamamura H, Lapidot T, Fujii N, Gronthos S. Zannettino AC, et al. Among authors: martin sk. Cancer Res. 2005 Mar 1;65(5):1700-9. doi: 10.1158/0008-5472.CAN-04-1687. Cancer Res. 2005. PMID: 15753365

3

NVP-BEZ235, a dual pan class I PI3 kinase and mTOR inhibitor, promotes osteogenic differentiation in human mesenchymal stromal cells.

Martin SK, Fitter S, Bong LF, Drew JJ, Gronthos S, Shepherd PR, Zannettino AC. Martin SK, et al. J Bone Miner Res. 2010 Oct;25(10):2126-37. doi: 10.1002/jbmr.114. J Bone Miner Res. 2010. PMID: 20499346 Free article.

4

Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation.

Martin SK, Fitter S, Dutta AK, Matthews MP, Walkley CR, Hall MN, Ruegg MA, Gronthos S, Zannettino AC. Martin SK, et al. Stem Cells. 2015 Apr;33(4):1359-65. doi: 10.1002/stem.1931. Stem Cells. 2015. PMID: 25537496

5

Osteocalcin-dependent regulation of glucose metabolism and fertility: Skeletal implications for the development of insulin resistance.

Tangseefa P, Martin SK, Fitter S, Baldock PA, Proud CG, Zannettino ACW. Tangseefa P, et al. Among authors: martin sk. J Cell Physiol. 2018 May;233(5):3769-3783. doi: 10.1002/jcp.26163. Epub 2017 Sep 18. J Cell Physiol. 2018. PMID: 28834550 Review.

6

The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.

Martin SK, Diamond P, Gronthos S, Peet DJ, Zannettino AC. Martin SK, et al. Leukemia. 2011 Oct;25(10):1533-42. doi: 10.1038/leu.2011.122. Epub 2011 Jun 3. Leukemia. 2011. PMID: 21637285 Review.

7

Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1alpha in patients with multiple myeloma.

Martin SK, Dewar AL, Farrugia AN, Horvath N, Gronthos S, To LB, Zannettino AC. Martin SK, et al. Clin Cancer Res. 2006 Dec 1;12(23):6973-7. doi: 10.1158/1078-0432.CCR-06-0323. Clin Cancer Res. 2006. PMID: 17145816

8

The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma.

Gan ZY, Fitter S, Vandyke K, To LB, Zannettino AC, Martin SK. Gan ZY, et al. Among authors: martin sk. Eur J Haematol. 2015 Apr;94(4):343-54. doi: 10.1111/ejh.12436. Epub 2014 Sep 17. Eur J Haematol. 2015. PMID: 25179233

9

The effect of the PI3K inhibitor BKM120 on tumour growth and osteolytic bone disease in multiple myeloma.

Martin SK, Gan ZY, Fitter S, To LB, Zannettino AC. Martin SK, et al. Leuk Res. 2015 Mar;39(3):380-7. doi: 10.1016/j.leukres.2014.12.015. Epub 2015 Jan 7. Leuk Res. 2015. PMID: 25624048

10

mTORC1 Plays an Important Role in Skeletal Development by Controlling Preosteoblast Differentiation.

Fitter S, Matthews MP, Martin SK, Xie J, Ooi SS, Walkley CR, Codrington JD, Ruegg MA, Hall MN, Proud CG, Gronthos S, Zannettino ACW. Fitter S, et al. Among authors: martin sk. Mol Cell Biol. 2017 Mar 17;37(7):e00668-16. doi: 10.1128/MCB.00668-16. Print 2017 Apr 1. Mol Cell Biol. 2017. PMID: 28069737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,963 results

Search Page

Filters